Assessing Inherited Markers of Metabolic Syndrome in the Young

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

700 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-02-28

Study Completion Date

2016-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The AIMM Young study is a collaboration between Children's National Medical Center (CNMC) and colleges/universities nationwide--currently including Howard University (HU), East Carolina University (ECU), and University of Massachusetts, Amherst (U Mass). This study obtains a variety of baseline measures (such as serum biomarkers related to metabolic syndrome, anthropometrics, muscle strength, and fitness testing) along with genetic information from healthy college-age (18-35 years) young adults in efforts to identify phenotype-genotype associations that may predispose individuals to developing metabolic syndrome, type 2 diabetes, and/or related diseases such as obesity.

We hypothesized that certain genetic variations will be protective against metabolic syndrome, while others will show a strong correlation with specific components of metabolic syndrome disease. We expect that the study of "pre-symptomatic," young individuals will facilitate the identification of genetic risk loci for metabolic syndrome and type 2 diabetes. Younger populations typically have less confounding variables, and this facilitates normalizing of metabolic syndrome features and environment/lifestyle. Additionally, young subjects can provide more robust longitudinal data, and be recruited into subsequent interventions to reverse the trend towards metabolic syndrome, rather than the more difficult task of reversing type 2 diabetes in older populations. The data collected will be stratified according to gender, age, ethnicity, genotype, and other phenotypic measures to determine how these factors influence disease risk.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pediatric Metabolic Syndrome Study

NCT03570840

Metabolic Syndrome Overweight and Obesity Cardiovascular Risk Factor

COMPLETED

Childhood Metabolic Markers of Adult Morbidity in Blacks

NCT01312051

Healthy Normal Weight Overweight

COMPLETED

Metabolically Healthy Obesity: Correlations Between BMI and Metabolic Syndrome Biomarkers

NCT03195712

Obesity

COMPLETED

Early Detection of Metabolic Syndrome and Obesity Comorbidities

NCT05681104

Metabolic Disorders in Children

NOT_YET_RECRUITING

To Investigate the Influence of Ethnicity in Metabolic Disease in Healthy, Overweight and Obese Subjects

NCT00988819

Healthy Overweight Obesity

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metabolic Syndrome Diabetes Mellitus, Type 2 Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy Young Adults

College-age (18-35 years) participants recruited from Howard University, East Carolina University, and University of Massachusetts, Amherst, University of Calgary, Winston-Salem University

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* between the ages of 18 and 35 years
* post-puberty
* willing and able to provide informed consent
* stable medical and psychosocial status providing a high likelihood of follow-up and compliance with study protocol
* all ethnic backgrounds will be included in this study.

Exclusion Criteria

* evidence of clinically relevant systemic disease associated with disorders of glucose metabolism
* chronic use of glucocorticoid or appetite suppressants
* concomitant use of drugs known to alter glucose metabolism (i.e., metformin, thiazolidinediones, sulfonylurea receptor agonists and inhibitors of alpha-glucoside hydrolase) or other medications known to alter blood levels being tested in this study
* inability to provide the requested fasting blood sample
* pregnancy
* menopause
* alcohol dependency (as determined by CAGE screening questionnaire); (8) inability to provide informed consent
* previous diagnosis or treatment for any hematologic-oncologic disorder
* history or current treatment for an eating disorder
* current treatment for weight loss
* history of bariatric surgery
* history of neurosurgical procedure
* participation in another clinical trial involving an investigational drug
* history of psychiatric disorder, which in the opinion of the investigator would affect the conduct of the proposed trial
* age younger than 18 or older than 35 at the time of recruitment
* weight that exceeds the capacity of equipment used for weight measurements.

Minimum Eligible Age

18 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes